Description
An alpha-lipoic acid complex, containing alpha-lipoic acid, R-alpha-lipoic acid, biotin, and calcium.
Prevention and/or treatment of diabetic complications associated with insulin resistance via ALA’s ability to increase glucose uptake and action as an antioxidant.Significantly reduces symptoms of diabetic pathologies, including cat act formation, vascular damage and polyneuropathyPatients receiving a daily oral dose of 500 mg of ALAx 3 weeks observed a significant reduction in pain, paresthesia, and numbness associated with chronic distal symmetric polyneuropathy.ALA and DHLA may reduce the risk of cardiovascular disease via beneficial actions on LDL oxidation, blood lipid profiles, plaque formation, and hypertension.
